GENERAL COMMENTS
This is a well-written protocol for a RCT using honey for treatment HSV. I really appreciate that investigators are going to use a novel approach to conducting RCTs in the community, using a pharmacybased research network and a unique electronic method to improve data collection.
However, I doubt that honey-based product (kanuka honey + glycerol) would be superior to a standard treatment. It might be useful to inform readers about the possible mechanism(s) how honey fights against HSV (just short statement: 2-4 sentences).
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1
This proposed trial has numerous strengths -novel research network, active comparator, addresses an important issue, etc.
One issue is the inclusion criteria. The second bullet says "active cold sore" but the next bullet says "within the 72 hour prodrome". these seem to be mutually exclusive as written.
Thank you for your encouraging comments and for pointing out the potential discrepancy in the inclusion criteria. This has been amended to 'Presenting for enrolment within the 72 hours of onset of symptoms' to clarify.
Reviewer: 2 This is a well-written protocol for a RCT using honey for treatment HSV. I really appreciate that investigators are going to use a novel approach to conducting RCTs in the community, using a pharmacy-based research network and a unique electronic method to improve data collection.
However, I doubt that honey-based product (kanuka honey + glycerol) would be superior to a standard treatment.
Thank you for your comment and opportunity to clarify this in the manuscript. The comparison of honey with aciclovir is justified on basis of the preliminary evidence from the main RCT to date (16) which reported reduced healing time with honey vs aciclovir. Also, medical grade honey is a valid comparator due to the relatively staged natural history of a herpes labialis episode. One might hypothesise that aciclovir would likely be more effective at aborting a cold sore episode prior to wound formation due to its potential in disrupting viral replication. Once a wound stage has been reached however it would be possible that the honey treatment is superior in terms of time to return to normal skin. In support of this hypothesis, the evidence base for honey use in wounds and bacterial infection is relatively expansive, however for a specific antiviral effect is minimal. In order to investigate this we have submitted an amendment to our statistical analysis plan and added further secondary outcome variables focused on detecting any potential benefit of either treatment, specific to a particular stage of a cold sore: 'Sensitivity analysis will be performed for both primary and secondary outcome variables, considering important potential confounders such as age, time to presentation from reported onset of symptoms and stage of cold sore at presentation. Interaction analysis will be performed for primary and secondary outcome variables, to assess potential differences in treatment effects from potential effect modifiers.'
It might be useful to inform readers about the possible mechanism(s) how honey fights against HSV (just short statement: 2-4 sentences).
Thank you for highlighting this point of omission. To address the limited evidence of the potential mechanisms whereby honey may exert an effect in the treatment of cold sores, we have added a sentence in the second paragraph as follows:
'Whether the efficacy of the honey product was due antiviral effects which have been demonstrated against HSV in vitro(7,17) and/or the numerous immunomodulatory effects which have been demonstrated in both vivo and vitro, was not assessed in this study(10)'
